Harvard Bioscience Posts 63 Percent Revenue Growth for Q2 | GenomeWeb

NEW YORK, July 28 - Harvard Bioscience today reported year-over-year revenue growth of 63 percent for the second quarter of 2003, after favorable foreign exchange effects, accompanied by a 25 percent decline in net income.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.